단백질 합성 조사 리뷰(2024년)

The global market for commercial amino acids is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

The global market for recombinant proteins is expected to grow from $141.8 billion in 2024 to $203.6 billion by 2029, at a CAGR of 7.5% from 2024 through 2029.

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 to $15.9 billion by 2028, at a CAGR of 9.4% from 2023 through 2028.

Research Review Scope

Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), ribosomes, and amino acids.

The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments towards cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques affect the growth of the market.

The market includes major players such as Amgen Inc., Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of protein-synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO007N Commercial Amino Acids.
• BIO254A Global Recombinant Proteins Market.
• BIO220B Oligonucleotides: Global Markets.
• BIO253A PEGylated Proteins Market.
• BIO252A Peptide Synthesis: Global Markets.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Commercial Amino Acids (BIO007N)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Commercial Interests
• Chemical Structure
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Challenges
• Market Opportunity
• Regulatory Structure
• Global Regulatory Framework
• Regulatory Requirements for Different Applications
• Quality Control and Manufacturing Standards
• Emerging Technologies and Developments
• Metabolic Engineering and Synthetic Biology
• High-throughput Screening and Fermentation Optimization
• Continuous-Flow Biocatalysis
• Advanced Chromatography Techniques
• Hydroxy Amino Acids
• Green Chemistry and Sustainable Production
• Key Market Trends
• Commercial Amino Acids: Global Markets
• Commercial Amino Acids Market, by Product Type
• Methionine
• Lysine
• Threonine
• Tryptophan
• Phenylalanine
• Glutamic Acid
• Cysteine
• Aspartic Acid
• Glycine
• Alanine
• Arginine
• Proline
• Leucine
• Valine
• Tyrosine
• Other Amino Acids
• Commercial Amino Acids Market, by Application
• Animal Feed Applications
• Food Flavoring Applications
• Specialty Uses Applications
• Commercial Amino Acids Market, by Region
• North America
• Europe
• Asia-Pacific
• LATAM
• Rest of the World
• Sustainability in Commercial Amino Acids: An ESG Perspective
• Introduction to ESG
• Sustainability in the Commercial Amino Acids Market
• Understanding the ESG Data

Chapter 3 Global Recombinant Proteins Market (BIO254A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Types of Expression Host Systems
• Mechanism of Action of Recombinant Proteins
• Common Steps Involved in Recombinant Protein Production
• Market Dynamics of Recombinant Proteins
• Drivers
• Restraints
• Opportunities
• Emerging Technologies and Developments in Recombinant Proteins
• Protein-Engineering Advances
• CRISPR Genome Editing
• Cell-Free Protein Synthesis
• Global Market for Recombinant Proteins, by Product Type
• Hormones
• Cytokines
• Enzymes
• Antibodies
• Antigens
• Others
• Global Market for Recombinant Proteins, by Host Cell Type
• Bacterial Host Cells
• Yeast and Fungi Cells
• Mammalian Cells
• Insect Cells
• Other Cells
• Global Market for Recombinant Proteins, by Application
• Therapeutics and Vaccines
• Biomedical Research
• Diagnostics
• Global Market for Recombinant Proteins, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Recombinant Proteins Market
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 4 Oligonucleotides: Global Markets (BIO220B)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• History of Oligonucleotide Synthesis
• Types of Oligonucleotides
• Alternative Forms of Oligonucleotide Synthesis
• Versatile Functions of Synthetic Oligonucleotides
• Regulatory Paths for Oligotherapeutics
• Animal Models and Studies
• Role of Regulatory Authorities
• Global Market Dynamics for Oligonucleotides
• Market Drivers
• Market Restraints
• Opportunities in the Market
• Emerging Applications in Various Fields
• Emerging Technologies and Developments in Oligonucleotides
• DNA Synthesizers
• Emerging Technologies
• Global Market for Oligonucleotide Synthesis, by Product Type
• Oligonucleotide Drugs
• Equipment and Reagents
• Synthesized Oligos
• Services
• Global Market for Oligonucleotide Synthesis, by Application
• Research
• Diagnostics and Therapeutics
• Global Market for Oligonucleotide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Developments in the Oligonucleotide Market
• Introduction to ESG
• Assessing the Sustainability of the Oligonucleotide Manufacturing Process
• ESG Performance in Market
• Concluding Remarks

Chapter 5 PEGylated Proteins Market (BIO253A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Advantages of Protein PEGylation
• Limitations of PEGylated Therapeutics
• Market Dynamics for the PEGylated Proteins
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Non-Covalent PEGylation
• PEGylation of Nanoparticles
• Antibody-Drug Conjugates (ADCs)
• Global PEGylated Proteins Market, by Protein Type
• Granulocyte-Colony Stimulating Factors (G-CSF)
• PEGylated Monoclonal Antibodies
• PEGylated Interferons
• PEGylated Recombinant Factors
• Other Protein Types
• Global PEGylated Proteins Market, by PEGylation Type
• Linear PEGylated Proteins
• Branched PEGylated Proteins
• Global PEGylated Proteins Market, by PEGylation Application
• Autoimmune Diseases
• Hematology
• Cancer
• Other Applications
• Global PEGylated Proteins Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in PEGylated Proteins Market: ESG Perspective
• Introduction to ESG
• Sustainability in the PEGylated Proteins Industry
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 6 Peptide Synthesis: Global Markets (BIO252A)

• Market Outlook
• Scope of Report
• Market Summary
• Peptide Therapeutics Market Overview
• Importance of Peptides
• Peptide Synthesis
• Trends in Peptide Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraint
• Market Opportunities
• Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
• Advances in SPPS in Aqueous Media
• Chemical Synthesis
• Peptide Drug Delivery
• Examples of New Developments, by Company
• Market Analysis, by Segment
• Global Market for Peptide Synthesis, by Peptide Type
• Synthetic Peptides
• Antimicrobial Peptides
• Hormonal Peptides
• Bioactive Peptides
• Collagen Peptides
• Other Products
• Global Market for Peptide Synthesis, by Application
• Peptide Therapeutics
• Cosmetics
• Nutraceuticals
• Other Applications
• Global Market for Peptide Synthesis, by Synthesis Type
• Solid-phase
• Solution-phase
• Hybrid-phase
• Global Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Peptide Synthesis Industry: ESG Perspective
• Importance of ESG among Peptide Therapeutics Manufacturers
• ESG Practices of Peptide Therapeutics Manufacturers
• BCC Research Viewpoint

Chapter 7 Appendix

• Research Methodology
• Analyst's Credentials